Reference | Outcome measure | Participants | Key Exclusions | First EEG start time after onset (h) | EEG Procedure | EEG Processing | EEG Biomarker | Result | Quality score |
---|---|---|---|---|---|---|---|---|---|
Sainio 1983 [41] | Admission and 7-day disability | 15 Ischaemic Stroke patients | TIA |  < 48 | 16 electrodes, eyes closed with checking for wakefulness | Online only, > 30 Hz, time constant 0.3 s, sampling 100 Hz | Relative spectral power (all bands), focal and background slowing | Poorer admission outcome associated with background (p = 0.00016) and focal (p = 0.0099) abnormalities, greater ipsilesional rolandic and occipital delta2 (p’s = 0.005) and less ipsilesional rolandic and occipital alpha (p = 0.005 and p = 0.025 respectively). Poorer 7-day outcome associated with background abnormalities (p = 0.0089) greater ipsilesional (p = .025) and contralesional (p = 0.025) delta2 and less ipsilesional alpha (p = 0.025) | 4 |
Charlin 2000 [42] | Day 90 mRS | 47 Ischaemic Stroke Patients | Epilepsy, cirrhosis, cancer, pre-stroke dependence; sedatives |  < 24 | 16 electrodes | None | PLEDs plus and PLEDS proper | Worse outcome (mRS > / = 3) associated with PLEDs (p = 0.03, AUC = 0.62, sensitivity = 30.8%, specificity = 93.75%). (prognostic accuracy extrapolated from true and false positive and negative values) | 3 |
Cuspineda 2003 [43] a | mRS at discharge and within three months | 28 Ischaemic Stroke patients (MCA territory) | Haemorrhage |  < 72 | 19 electrodes, awake, eyes open and closed, reclining, temperature controlled | Online filters 0.3-30 Hz, notch 60 Hz, manual artifact removal, 2.56 s epochs | Absolute spectral power (absolute energy) | Discharge and 3-month outcome (mRS) predicted by assessment of EEG absolute energy variables with 100% accuracy (r = 0.99). QEEG predicted outcome at discharge better than the CaNS (p = 0.03) | 2 |
Cuspineda 2007 [44] a | mRS at discharge and within three months | 28 Ischaemic Stroke patients (MCA territory) | Haemorrhage |  < 72 | 19 electrodes, awake, eyes open and closed, reclining, temperature controlled | Online filters 0.3-30 Hz, notch 60 Hz, manual artifact removal, 2.56 s epochs | Absolute spectral power (all bands Absolute Energy) | Poorer outcome at discharge (mRS) predicted by.less alpha (Accuracy = 92.3% r = 0.95) and beta (Accuracy = 69.2%, r = 0.76) and greater theta (Accuracy = 92.3%, r = 0.94) and delta (Accuracy = 84.6%, r = 0.85) power within 24 h. Poorer outcome at 3 months predicted by less alpha (Accuracy = 88.9%, r = 0.97) and beta (Accuracy = 77.8%, r = 0.83)and greater delta (Accuracy = 88.9%, r = 0.92, r 0.87) and theta (Accuracy = 77.8%, r = 0.83) within 24-48 h | 4 |
Sheorajapanday 2011 [15] | Day 7 mRS | 60 Ischaemic Stroke patients | Mass lesion; ICH; seizure(s); hypo/hyperglycaemia | Most < 72 | 19 electrodes, eye closed, awake/alert | Online montage re-referencing; filters > 0.3 Hz, < / = 30 Hz, manual artifact removal, 128 s epochs, FFT | Relative spectral power (DTABR), BSI | Greater DTABR predicted unfavourable outcome (mRS score >  = 2) in LACS (AUC = 0.88; accuracy = 0.83%, p = 0.01) but not in POCS | 5 |
Su 2013 [45] | Three-month mRS | 162 Ischaemic Stroke patients (large MCA infarct) | Pre-stroke dependence, concurrent illness affecting outcome, sedatives; extraneous factors affecting consciousness |  < 72 | 8 electrodes; pain and auditory stimulation | Online filter 0.5-70 Hz, time constant 0.3 ms | Dominant fast/slow wave with/without reactivity, RAWOD, epileptiform activity, burst and general suppression; alpha/theta coma | Significant associations between worse outcome (mRS > 4) and RAWOD (OR = 2.47, sensitivity = 37%, specificity = 85%) and good outcome and dominant alpha with reactivity (OR = .08, but poor sensitivity = 7.4%, specificity = 49.3%). All other markers had > 80% specificity but < 40% sensitivity in predicting poor outcome. Modified grading most accurate (Kappa = 0.61, p = 0.04, sensitivity = 77.9%, specificity = 89.6%, accuracy = 91.4%) | 4 |
Lima 2017 [46] | Three-month mRS | 157 Ischaemic Stroke patients (19 with seizures) | Previous seizures, debilitating neurological disorders, hypo/hyperglycaemia |  < 45.5 | 19 electrodes | None | Epileptiform activity (IED and PP) | Worse outcome (mRS > / = 3) associated with epileptiform activity (OR = 2.94, p = 0.001) but not when seizures excluded (OR = 2.13, p = 0.07). AUC = 0.60, sensitivity = 51.3%, specificity = 69%). (prognostic accuracy extrapolated from true and false positive and negative values) | 4 |
Bentes 2017 [47] a | mRS (including mortality) at discharge and within 1 year | 151 Ischaemic Stroke patients (ICA; NIHSS 4–42) | Prestroke dependence, traumatic brain injury or surgery, hydrocephalus, history of epilepsy |  < 72 | 64 electrodes, eyes open and closed, resting, hyperventilation and photic stimulation | Not Reported | Asymmetry, Suppression, focal slow-waves, epileptiform activity; periodic discharges | Worse outcome (mRS > / = 3) at discharge associated with EEG background (OR = 5.55, p = 0.002) slowing, asymmetry (OR = 11.91, p < 0.001) and periodic discharges (OR = 10.39, p = 0.027). Worse outcome at 1 year predicted by background slowing (OR = 14.50, p < 0.001) and asymmetry (OR = 22.73, p > 0.001) and periodic discharges (OR = 14.1, p = 0.002). Clinical and radiological predictors plus background asymmetry (AUC = 0.91, sensitivity = 81.1%, specificity = 88.7%) was a better model than clinical data plus past seizures (AUC = 0.83, sensitivity = 72.1%, specificity = 77.5%), clinical (AUC = 0.82, sensitivity = 70.3%, specificity = 73.2%), asymmetry (AUC = 0.81, sensitivity = 72.7%, specificity = 89%) and past seizures (AUC = 0.59, sensitivity = 25.7%, specificity = 93.2%) in isolation. 12-month mortality associated with EEG acute symptomatic seizures (OR = 4.55, p = 0.015) and EEG suppression (OR = 7.48, p = 0.019). Clinical/radiological predictors plus EEG suppression (AUC = 0.84, sensitivity = 31.8%, specificity = 99.2%) were a better predictor than clinical data plus acute seizures (AUC = 0.82, sensitivity = 40.9%, specificity = 100%), and clinical data (AUC = 0.81, sensitivity = 22.7%, specificity = 98.4%), acute seizures (AUC = 0.64, sensitivity = 0%, specificity = 100%), and suppression (AUC = 0.61, sensitivity = 26.1%, specificity = 96.1%) in isolation | 5 |
Xin 2017 [48] | BI/mRS at 21 days | 29 Ischaemic Stroke patients | TIA, ICH, previous stroke, cardiovascular disorders, traumatic brain injury, tumour, ‘serious disease’, pregnancy |  < 72 | 16 electrodes, < 3 h after meal; sedatives discontinued 3 days prior | Online and offline, filters < 0.53 Hz, > 50 Hz. Sampling 100 Hz, EOG, ECG, EMG, visual and wavelet transform artifact removal, 10 s epochs | r-BSI | Worse outcome (lower BI and higher mRS) associated with higher r-BSI at admission (BI -2.070, P = 0.049, mRS 2.256, P = 0.033) | 3 |
Bentes 2018 [49] a | mRS at discharge and one year | 151 Ischaemic Stroke patients (ICA;NIHSS 4–42) | Prestroke dependence, traumatic brain injury or surgery, hydrocephalus, history of epilepsy |  < 72 | 64 electrodes, eyes open and closed, resting, hyperventilation and photic stimulation | Offline filters < / = 0.5 Hz, > 70 Hz, notch 50 Hz, manual and automatic artifact removal, 2.05 s epochs; FFT | Absolute spectral power (all bands, DAR, DTABR); BSI | Worse outcome (mRS > / = 3) associated with greater delta (discharge AUC = 0.812, OR = 125; 12 months AUC = 0.836, OR = 129.8), and DTABR (discharge AUC = 0.827, OR = 1.702; 12 months AUC = 0.859, OR = 1.668) and less alpha (discharge AUC = 0.814, OR = 0.221; 12 months AUC = 0.852, OR = 0.16) and beta (discharge AUC = 0.803, OR = 0.28; 12 months AUC = 0.829, OR = 0.28) power (all p > 0.001; theta not significant). The best discharge models combined clinical/radiological predictors with background asymmetry (AUC = 0.831, sensitivity = 81.3%, specificity = 68%), DTABR (AUC = 0.827, sensitivity = 87.5%, specificity = 60%), alpha power (AUC = 0.756, sensitivity = 86.9%, specificity = 46.2%) and background slowing (AUC = 0.787, sensitivity = 82.3%, specificity = 60%). The best 12-month models combined clinical/radiological predictors with background asymmetry (AUC = 0.89, sensitivity = 81.1%, specificity = 88.7%), background slowing (AUC = 0.866, sensitivity = 78.4%, specificity = 87.3%), DTABR (AUC = 0.859, sensitivity = 79.7%, specificity = 74.6%) and alpha (AUC = 0.852, sensitivity = 75.7%, specificity = 78.9%). Isolated clinical data, followed by DTABR and alpha were good predictors (AUC’s = 0.768–0.794, sensitivity = 70.1–76.6%, specificity = 64.4–71.8%) (all p > 0.001) | 4 |
Kuznietsov 2018 [50] | 21-day mRS | 103 Ischaemic Stroke patients (supratentorial) | Cardiovascular or psychiatric disorders, traumatic brain injury, ICH, tumour, past seizure(s) |  < 72 | 19 electrodes | Offline independent component analysis artifact removal, 60 s epochs; FFT | Absolute and relative spectral power (All bands, RSRP; FORG; IHRA) | Worse outcome post-stroke (mRS) associated with higher RSRP of delta band in contralesional hemisphere > 18.4% (OR = 1.31, p = 0.0004; AUC = 0.94, sensitivity = 87.0%, specificity = 87.7%, p < 0.0001), lower FORG of alpha band in ipsilesional hemisphere > -0.066 (OR = 29.07, p = 0.0224; AUC = 0.74, sensitivity = 67.4%, specificity = 70.0%, p < 0.0001) and IHRA of alpha band ≤ -0.066 (OR = 0.01, p = 0.0402; AUC = 0.66, sensitivity = 60.9%, specificity = 70.2%, p < 0.0039). No significant differences for other biomarkers | 3 |
Rogers 2020 [51] | 30 and 90-Day mRS and mBI | 12 Ischaemic Stroke patients, 4 Haemorrhagic Stroke patients | Neurological/psychiatric disorders |  < 72 | Single electrode at 10–20 FP1, eyes closed | Online sampling and amplification, Offline filter 0.5-30 Hz, manual and automatic artifact removal, 4 s epochs; FFT | Absolute and relative spectral power (all bands, DAR, DTR, DTABR) | Only relative theta power significantly negatively correlated with mRS (30-day r = -0.54; 90-day r = -0.53) and positively with mBI (30-day r = 0.60; 90-day r = 0.45). Better outcome post-stroke (mBI > / = 95; mRS < / = 1) associated with higher theta values >  = 0.25 for 30-day mRS (AUC = 0.81, sensitivity = 71.4%, specificity = 88.9%, p = 0.04), mBI (AUC = 0.90, sensitivity = 83.3%, specificity = 90%, p < 0.01) and 90-day mBI (AUC = 0.82, sensitivity = 80%, specificity = 81.8%, p = 0.05) but not 90-day mRS (AUC = 0.75, sensitivity = 62.5%, specificity = 87.5%, p = 0.09). EEG theta power was a no more accurate predictor than NIHSS | 4 |
Juhasz 1997 [52] | Modified NIHSS at 1 month | 40 Ischaemic Stroke patients | Bilateral stroke |  < 48 | 16 electrodes | Online filters < / = 0.3, > 30, 4 s and 80 s epochs, artifacts removed | Absolute spectral power (alpha, beta); APF | Worse outcome (NIHSS) post stroke significantly associated with > 0.5 Hz difference in interhemispheric APF (p < 0.02) | 3 |
Vespa 2003 [38] |  < 72 h NIHSS and GOS at discharge | 46 Ischaemic Stroke patients, 63 Haemorrhagic Stroke patients (NIHSS 8–42) | Traumatic haemorrhage, SAH, ICH; Brainstem stroke |  < 24 | 14 electrodes | Online (hospital staff) or offline (EEG segment review or total power trend) seizure detection and classification (focal, hemispheric or generalised) | Epileptiform activity | EEG seizures showed no association with GOS 4–5 (p = 0.25) but differed significantly according to NIHSS < 72 h (p = 0.05) | 4 |
Finnigan 2004 [12] | 30 Day NIHSS | 11 Ischaemic stroke patients | Fever, encephalitis, seizures, ICH, non-cortical stroke, confounding neurological condition (e.g. previous stroke) or medication |  < 9 | 64(62) electrodes, alert or drowsy | Online filter .01-100 Hz, artifacts 0.2- 40 Hz, automatic artifact removal, 4 s epochs, sampling 500 Hz, FFT .5-50 Hz | Relative spectral power (aDCI) | Worse outcome (higher NIHSS) associated with greater aDCI (rho = 0.80, P < 0.01) | 3 |
Finnigan 2007 [53] | 30 Day NIHSS | 13 Ischaemic Stroke patients | Fever, encephalitis, seizures, ICH, confounding neurological condition (e.g. previous stroke) or medication |  < 52 | 62 electrodes, alert or drowsy | Online filter .01-100 Hz, artifacts 0.2- 40 Hz, EOG artifact removal, 4 s epochs, sampling 500 Hz, FFT .5-50 Hz | Relative spectral power (delta, theta, alpha; beta); DAR | Worse outcome (NIHSS) was associated with greater DAR (r = 0.91, P < 0.001) and less relative alpha power (r = -0.82, P < 0.01). These correlations were also observed in a 19-channel subset | 3 |
Wolf 2016 [40] | Admission and discharge NIHSS | 69 Ischaemic Stroke patients | Epileptic seizures |  < 48 | 10–20 system | Not Reported | Epileptiform activity; focal slowing | Worse outcome post-stroke (deterioration of NIHSS > 3 points admission vs discharge) associated with generalised EEG slowing (p = 0.003) | 2 |
Yang 2017 [24] | 7, 14 & 90 Day NIHSS | 86 Ischaemic Stroke patients (NIHSS 4–24) | Cardiovascular disorders, pregnancy |  < 4.5 | 20 electrodes | Online filter .16-70 Hz, sampling 250 Hz, FFT | Relative spectral power (DAR, DTABR), BSI | Neurological improvement of patients post-thrombolysis (decrease in NIHSS by 8 points or return to normal) significantly associated with early decrease in BSI (2 h), DAR (2 h) and DTABR (24 h) (both p < 0.01) | 4 |
De Herdt 2018 [54] | Day 7 NIHSS | 29 Ischaemic Stroke patients, 2 Haemorrhagic stroke patients | Not Reported |  < 72 | Not Reported | Not Reported | Epileptiform activity (spikes, spike-waves; seizure, PLEDs) | Epileptiform activity not associated with outcome, only useful for predicting seizure incidence (abstract only—no statistics provided) | 2 |
Gur 1994 [55] | Dementia diagnosis, checked every 6 months for 2 years | 199 Ischaemic Stroke patients | Cognitive impairment, TIA, ICH, previous stroke |  < 48 | 18 electrodes | Not Reported | Abnormal EEG patterns, foci, background slowing | Worse outcome (development of dementia) associated with abnormal EEG (OR = 2.6, p = 0.003, AUC = 0.38, sensitivity = 63.4%, specificity = 12.2%) (prognostic accuracy extrapolated from true and false positive and negative values) | 3 |
Wang 2013 [39] | MoCA at two weeks and 2 years | 110 Ischaemic Stroke patients | Cognitive impairment, psychiatric disorders, traumatic brain injury, tumour, infection, multi-infarct, systemic disease, psychoactive drug use |  < 10 | 16 electrodes | Sampling 250 Hz, offline filter 0.5-50 Hz, computer, visual and EOG artifact removal, 2 s epochs, | Relative spectral power (beta only) | Significantly lower beta power with cognitive impairment and larger infarct size (P < 0.01). Sensitivity: 92.3% for predicting impairment and 93.3% for predicting normal cognition. Good concordance between MoCA scores and beta power (Kappa statistic = 0.851, p < 0.001) | 3 |
Song 2015 [56] | MoCA (Beijing version) 11 months—7 years | 105 Ischaemic Stroke Patients | Cognitive impairment, psychiatric disorders, traumatic brain injury, tumour, infection, multi-infarct, systemic disease, psychoactive drug use |  < 12 | 16 electrodes, eyes closed with checking for wakefulness | Online filter 0.5-50 Hz, Offline 2 s epochs, EOG artifact removal, FFT | Relative spectral power (all bands) | Worse outcome associated with high background rhythm frequency (HR = 14 (3.8, 41), P < 0.001) or greater median theta power (HR = 5 (1.4, 7.8), P = 0.002) | 4 |
Aminov 2017 [25] | 90 Day MoCA | 15 Ischaemic Stroke patients, 4 Haemorrhagic Stroke patients | Neurological/psychiatric disorders, previous stroke |  < 72 | Single electrode at FP1, eyes closed | Online filter 0.5-30 Hz, manual artifact removal, 4 s epochs; FFT | Relative spectral power (DAR, DTR) | Better outcome moderately correlated with higher relative theta power (r = 0.50, p = 0.01), lower DAR (r = -0.45, p = 0.03), DTR (r = -0.57, p = 0.01) and relative delta power (r = -0.47, p = 0.02) | 4 |
Yan 2011 [28] | Mortality | 22 Stroke patients | Not Reported |  < 48 | 16 electrodes, eyes closed, resting | Offline visual artifact removal followed by digital filter, 10 s epochs. FFT | BBSI | BBSI > 0.082 predicted mortality with an accuracy of 86.36% | 2 |
Chen 2018 [30] | Mortality at Day 90 | 47 Haemorrhagic Stroke patients | Aneurysm, vascular malformation, traumatic head/brain injury, tumour, infection/encephalitis |  < 59 | 16 electrodes, eyes closed and awake; supine | Offline filters > 0.3, < / = 30 Hz, artifacts removed. FFT | Relative spectral power delta, alpha, DAR, DTABR), BSI | Mortality at Day 90 was associated with higher DAR (OR 5.306, p = 0.008). AUC for TCD-QEEG(DAR) model = 0.949 | 4 |
Jiang 2019 [57] | Mortality at discharge and six months | 58 Ischaemic Stroke patients | Prestroke dependence, consciousness altering drugs, haemorrhage, tumour, encephalitis, epilepsy |  < 72 | 16 electrodes | Online filters 0.5-30 Hz and offline visual artifact rejection. FFT | Relative spectral power (All bands, DTABR), BSI | Mortality at discharge and six months post-stroke associated with greater contralateral electrode theta power > / = 25.53 (discharge p = .038, accuracy = 68%, sensitivity = 69.2%, specificity = 66.7%), 6-month p = 0.026, accuracy = 64%, sensitivity = 45.2%, specificity = 94.7%). No other biomarkers significantly contributed to the model | 4 |